TissGeneSummary for LCAT |
Gene summary |
Basic gene information | Gene symbol | LCAT |
Gene name | lecithin-cholesterol acyltransferase | |
Synonyms | - | |
Cytomap | UCSC genome browser: 16q22.1 | |
Type of gene | protein-coding | |
RefGenes | NM_000229.1, | |
Description | phosphatidylcholine-sterol acyltransferasephospholipid-cholesterol acyltransferase | |
Modification date | 20141207 | |
dbXrefs | MIM : 606967 | |
HGNC : HGNC | ||
Ensembl : ENSG00000213398 | ||
HPRD : 06098 | ||
Vega : OTTHUMG00000137551 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_LCAT | |
BioGPS: 3931 | ||
Pathway | NCI Pathway Interaction Database: LCAT | |
KEGG: LCAT | ||
REACTOME: LCAT | ||
Pathway Commons: LCAT | ||
Context | iHOP: LCAT | |
ligand binding site mutation search in PubMed: LCAT | ||
UCL Cancer Institute: LCAT | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | TiGER,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | LiverProstate | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | LIHCPRAD | |
Reference showing the relevant tissue of LCAT | ||
Description by TissGene annotations |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID | GO:0006644 | phospholipid metabolic process | 4335615 | GO:0006656 | phosphatidylcholine biosynthetic process | 11966470 | GO:0008203 | cholesterol metabolic process | 10559507 | GO:0030301 | cholesterol transport | 10559507 | GO:0034372 | very-low-density lipoprotein particle remodeling | 15654758 | GO:0034375 | high-density lipoprotein particle remodeling | 10722751 | GO:0034435 | cholesterol esterification | 3458198 | GO:0042632 | cholesterol homeostasis | 4335615 | GO:0043691 | reverse cholesterol transport | 4335615 | GO:0006644 | phospholipid metabolic process | 4335615 | GO:0006656 | phosphatidylcholine biosynthetic process | 11966470 | GO:0008203 | cholesterol metabolic process | 10559507 | GO:0030301 | cholesterol transport | 10559507 | GO:0034372 | very-low-density lipoprotein particle remodeling | 15654758 | GO:0034375 | high-density lipoprotein particle remodeling | 10722751 | GO:0034435 | cholesterol esterification | 3458198 | GO:0042632 | cholesterol homeostasis | 4335615 | GO:0043691 | reverse cholesterol transport | 4335615 |
Top |
TissGeneExp for LCAT |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
LIHC | 1.777357309 | 5.464339309 | -3.686982 | 1.81E-17 | 8.74E-16 |
BRCA | -2.116815778 | -0.40491841 | -1.711897368 | 7.06E-45 | 3.06E-43 |
LUSC | -1.432673828 | 0.082122251 | -1.514796078 | 2.81E-15 | 1.81E-14 |
LUAD | -1.36129276 | -0.119653104 | -1.241639655 | 1.61E-13 | 1.38E-12 |
Top |
TissGene-miRNA for LCAT |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for LCAT |
TissGeneSNV for LCAT |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.S132Y | KIRP | 1 |
p.S138G | STAD | 1 |
p.P278S | CESC | 1 |
p.Q220H | UCEC | 1 |
p.D101N | COAD | 1 |
p.I269K | KICH | 1 |
p.L324I | READ | 1 |
p.V49I | UCEC | 1 |
p.R47Q | UCEC | 1 |
p.E179D | LUAD | 1 |
p.G332D | STAD | 1 |
p.T12P | LIHC | 1 |
p.E178K | ESCA | 1 |
p.F32I | BRCA | 1 |
p.G239V | LIHC | 1 |
p.S279C | HNSC | 1 |
p.D301N | LUAD | 1 |
p.P344L | LIHC | 1 |
p.R280H | UCEC | 1 |
p.R182H | STAD | 1 |
p.E179* | LUAD | 1 |
p.S249L | BLCA | 1 |
p.A282V | UCEC | 1 |
p.V288M | STAD | 1 |
p.P256S | CESC | 1 |
p.R164C | STAD | 1 |
p.I231M | LUAD | 1 |
p.A117T | GBM | 1 |
p.G239V | KIRP | 1 |
p.D367H | CESC | 1 |
p.F230S | PRAD | 1 |
p.A330V | COAD | 1 |
Top |
TissGeneCNV for LCAT |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for LCAT |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Chimerdb3.0 | ChiTaRs | NA | X06537 | RPL13A-LCAT | chr19:49995310 | chr16:67973786 |
Top |
TissGeneNet for LCAT |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for LCAT |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for LCAT |
TissGeneDrug for LCAT |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for LCAT |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0023195 | Lecithin Acyltransferase Deficiency | 36 | BeFree,CLINVAR,CTD_human,GAD,LHGDN,MGD,ORPHANET,UNIPROT |
umls:C0342895 | Fish-Eye Disease | 21 | BeFree,CLINVAR,GAD,MGD,ORPHANET,UNIPROT |
umls:C0004153 | Atherosclerosis | 14 | BeFree,GAD,LHGDN |
umls:C0003850 | Arteriosclerosis | 11 | BeFree |
umls:C0242339 | Dyslipidemias | 4 | BeFree,GAD |
umls:C0010054 | Coronary Arteriosclerosis | 3 | BeFree,GAD |
umls:C0010068 | Coronary heart disease | 3 | BeFree,GAD |
umls:C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 3 | GAD |
umls:C0020473 | Hyperlipidemia | 3 | GAD,LHGDN,RGD |
umls:C0022661 | Kidney Failure, Chronic | 3 | BeFree,RGD |
umls:C0035078 | Kidney Failure | 3 | BeFree |
umls:C1956346 | Coronary Artery Disease | 3 | BeFree,LHGDN |
umls:C0007222 | Cardiovascular Diseases | 2 | BeFree |
umls:C0022658 | Kidney Diseases | 2 | BeFree |
umls:C0023817 | Hyperlipoproteinemia Type I | 2 | BeFree |
umls:C0028754 | Obesity | 2 | BeFree |
umls:C0154251 | Lipid Metabolism Disorders | 2 | BeFree,GAD |
umls:C0342883 | Cholesteryl Ester Transfer Protein Deficiency | 2 | BeFree |
umls:C0473527 | Hypoalphalipoproteinemias | 2 | GAD |
umls:C1704429 | Hypoalphalipoproteinemia, Familial | 2 | BeFree |
umls:C0002395 | Alzheimer's Disease | 1 | GAD |
umls:C0005684 | Malignant neoplasm of urinary bladder | 1 | GAD |
umls:C0007785 | Cerebral Infarction | 1 | LHGDN |
umls:C0020476 | Hyperlipoproteinemias | 1 | BeFree |
umls:C0020557 | Hypertriglyceridemia | 1 | GAD |
umls:C0021368 | Inflammation | 1 | GAD |
umls:C0021655 | Insulin Resistance | 1 | GAD |
umls:C0023895 | Liver diseases | 1 | BeFree |
umls:C0024117 | Chronic Obstructive Airway Disease | 1 | GAD |
umls:C0025521 | Inborn Errors of Metabolism | 1 | BeFree |
umls:C0027051 | Myocardial Infarction | 1 | RGD |
umls:C0155733 | Atherosclerosis of aorta | 1 | BeFree |
umls:C0242379 | Malignant neoplasm of lung | 1 | GAD |
umls:C0497327 | Dementia | 1 | GAD |
umls:C1522137 | Hypertriglyceridemia result | 1 | GAD |
umls:C3711531 | Hdl Deficiency, Type 2 | 1 | BeFree |